|
Market Closed -
NSE India S.E.
15:05:10 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,801.00 INR | -0.86% |
|
-2.76% | +4.73% |
| Market Cap | 4,321B 44.87B 39.88B 37.18B 33.89B 63.94B 64.54B 451B 175B 2,204B 168B 165B 7,086B | P/E 2027 * |
33.2x | P/E 2028 * | 28.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4,051B 42.06B 37.39B 34.85B 31.76B 59.94B 60.49B 422B 164B 2,066B 158B 154B 6,642B | EV / Sales 2027 * |
6.22x | EV / Sales 2028 * | 5.46x |
| Free-Float |
44.39% | Yield 2027 * |
0.95% | Yield 2028 * | 1.11% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUNPHARMA | Delayed | |
Bombay S.E.
| SUNPHARMA | Delayed |
Last Transcript: Sun Pharmaceutical Industries Ltd.
| 1 day | -0.86% | ||
| 1 week | -2.76% | ||
| Current month | -0.86% | ||
| 1 month | -6.77% | ||
| 3 months | -3.74% | ||
| 6 months | +6.34% | ||
| Current year | +4.73% |
| 1 week | 1,792.6 |  | 1,865 |
| 1 month | 1,792.6 | | 1,917.3 |
| Current year | 1,583.7 | | 2,046.9 |
| 1 year | 1,583.7 | | 2,046.9 |
| 3 years | 1,068.35 | | 2,046.9 |
| 5 years | 733.7 | | 2,046.9 |
| 10 years | 312 | | 2,046.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 59 | 01/09/2025 | |
| Director of Finance/CFO | 58 | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 01/09/2025 | |
| Director/Board Member | 73 | 25/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -2.76% | +10.07% | +55.44% | 44.95B | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.77% | -3.32% | +25.46% | +56.98% | 374.21B | |
| Weighted average by Cap. | -0.60% | -3.32% | +30.27% | +68.79% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 651B 6.76B 6.01B 5.6B 5.11B 9.63B 9.72B 67.9B 26.33B 332B 25.38B 24.83B 1,068B | 730B 7.58B 6.73B 6.28B 5.72B 10.79B 10.9B 76.07B 29.5B 372B 28.44B 27.82B 1,196B |
| Net income | 129B 1.34B 1.19B 1.11B 1.01B 1.91B 1.93B 13.49B 5.23B 65.97B 5.04B 4.93B 212B | 154B 1.59B 1.42B 1.32B 1.2B 2.27B 2.29B 16.02B 6.21B 78.32B 5.99B 5.86B 252B |
| Net Debt | -271B -2.81B -2.5B -2.33B -2.12B -4.01B -4.04B -28.23B -10.94B -138B -10.55B -10.32B -444B | -338B -3.51B -3.12B -2.91B -2.65B -5.01B -5.05B -35.29B -13.68B -173B -13.19B -12.91B -555B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | ₹1,801.00 | -0.86% | 2,314,700 |
| 30/09/26 | ₹1,816.60 | -2.60% | 2,401,495 |
| 29/09/26 | ₹1,865.00 | +1.47% | 3,083,083 |
| 28/09/26 | ₹1,838.00 | -0.77% | 947,719 |
| 25/09/26 | ₹1,852.20 | +0.12% | 683,246 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
